CORC

在结果中检索

CORC

浏览/检索结果: 共54条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer 期刊论文
ADVANCED MATERIALS, 2021, 页码: 37
作者:  Saeed, Madiha;  Chen, Fangming;  Ye, Jiayi;  Shi, Yang;  Lammers, Twan
收藏  |  浏览/下载：37/0  |  提交时间：2021/08/17
Out-of-the-Box Nanocapsules Packed with On-Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy 期刊论文
ADVANCED HEALTHCARE MATERIALS, 2021
作者:  Zhao, Di;  Jiang, Kai;  Wang, Yuqi;  Cheng, Jin;  Mo, Fangli
收藏  |  浏览/下载：122/0  |  提交时间：2021/03/15
Synthesis and evaluation of new thiourea derivatives as antitumor and antiangiogenic agents 期刊论文
TETRAHEDRON LETTERS, 2020, 卷号: 61, 期号: 40
作者:  Bai, Wenjing;  Ji, Jianxin;  Huang, Qiang;  Wei, Wei
收藏  |  浏览/下载：9/0  |  提交时间：2020/11/25
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 11
作者:  Liang, Qian;  Kong, Lingxin;  Du, Yang;  Zhu, Xu;  Tian, Jie
收藏  |  浏览/下载：52/0  |  提交时间：2019/12/16
Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging 期刊论文
CANCER LETTERS, 2019, 卷号: 453, 页码: 74-83
作者:  Liu, Shengnan;  Du, Yang;  Ma, He;  Liang, Qian;  Zhu, Xu
收藏  |  浏览/下载：49/0  |  提交时间：2019/07/12
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 卷号: 8, 期号: 5, 页码: 575-+
作者:  Wang, Lili;  He, Zhen;  Yang, Sen;  Tang, Hong;  Wu, Yufeng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/11
PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis 期刊论文
BIOCHEMICAL PHARMACOLOGY, 2018, 卷号: 150, 页码: 131-140
作者:  Fang, Xiaona;  Xie, Hua;  Luo, Min;  Chen, Zhen;  Wang, Fang
收藏  |  浏览/下载：34/0  |  提交时间：2019/01/08
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor 期刊论文
CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219
作者:  Xie, Chengying;  Wan, Xiaozhe;  Quan, Haitian;  Zheng, Mingyue;  Fu, Li
收藏  |  浏览/下载：43/0  |  提交时间：2019/01/08
A phase II study of apatinib in patients with recurrent epithelial ovarian cancer 期刊论文
Gynecologic Oncology, 2018, 卷号: 148, 期号: 2, 页码: 286-290
作者:  Miao, Mingming;  Deng, Guanming;  Luo, Sujuan;  Zhou, Jiajia;  Chen, Le
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03
Advanced Scrotal Extramammary Paget\'s Disease Treated With Apatinib: A Case Report 期刊论文
Clin Genitourin Cancer, 2018, 卷号: Vol.16 No.2, 页码: e339-e342
作者:  Zhang, YN;  Chen, Y;  Gao, F;  Chen, N;  Liu, JY
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace